FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ferriprox (deferiprone) filed by Chiesi USA, Inc., resulting in updated labeling for iron chelation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload
• Thalassemia

Drugs mentioned

• FERRIPROX (deferiprone)

Snippet

SUPPL AP for FERRIPROX (DEFERIPRONE)